middle.news
How Proteomics International’s Blood Test Could Revolutionize Early Esophageal Cancer Detection
8:45am on Monday 8th of September, 2025 AEST
•
Healthcare
Read Story
How Proteomics International’s Blood Test Could Revolutionize Early Esophageal Cancer Detection
8:45am on Monday 8th of September, 2025 AEST
Key Points
PromarkerEso identifies early-stage esophageal adenocarcinoma with up to 91% sensitivity
Non-invasive blood test offers alternative to costly, uncomfortable endoscopy procedures
Study of 350 participants validates test’s accuracy across cancer stages and Barrett’s Esophagus
PromarkerEso uses proprietary biomarker algorithm combining proteins and clinical factors
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Proteomics International Laboratories (ASX:PIQ)
OPEN ARTICLE